0001700389-17-000001.txt : 20170523 0001700389-17-000001.hdr.sgml : 20170523 20170523163731 ACCESSION NUMBER: 0001700389-17-000001 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20170523 DATE AS OF CHANGE: 20170523 EFFECTIVENESS DATE: 20170523 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Kleo Pharmaceuticals, Inc. CENTRAL INDEX KEY: 0001700389 IRS NUMBER: 475508437 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-287320 FILM NUMBER: 17864221 BUSINESS ADDRESS: STREET 1: 25 SCIENCE PARK, SUITE 2D STREET 2: 150 MUNSON ST. CITY: NEW HAVEN STATE: CT ZIP: 06511 BUSINESS PHONE: 203-691-6332 MAIL ADDRESS: STREET 1: 25 SCIENCE PARK, SUITE 2D STREET 2: 150 MUNSON ST. CITY: NEW HAVEN STATE: CT ZIP: 06511 D 1 primary_doc.xml X0707 D LIVE 0001700389 Kleo Pharmaceuticals, Inc. 25 SCIENCE PARK, SUITE 2D 150 MUNSON ST. NEW HAVEN CT CONNECTICUT 06511 203-691-6332 DELAWARE None None Corporation true 2015 David Spiegel 25 Science Park, Suite 2D 150 Munson Street New Haven CT CONNECTICUT 06511 Executive Officer Director Roy Prieb 25 Science Park, Suite 2D 150 Munson Street New Haven CT CONNECTICUT 06511 Executive Officer Director Declan Doogan 45 Ocean Crest Way Unit 1032 Palm Coast FL FLORIDA 32137 Director John W. Childs c/o J.W. Childs Associates, L.P. 500 Totten Pond Road, 6th Floor Waltham MA MASSACHUSETTS 02451 Director Charles G. Drake c/o Columbia University Medical Center 177 Fort Washington Avenue, St. 6GN-435 New York NY NEW YORK 10032 Director Pharmaceuticals Decline to Disclose 06b false 2017-02-28 true true false 2500 Indefinite 19403470 Indefinite false 23 0 true 0 true 0 true false Kleo Pharmaceuticals, Inc. /s/ David Spiegel David Spiegel Chief Executive Officer 2017-05-23